Products

Bupivacaine HCl 14252-80-3//Carboplatin 41575-94-4//Doxepin HCl 1229 -29-4//Sodium Tauroglycocholate 41945-48-6//Nepafenac 78281-72-8//Alogliptin 850649-61-5

China Bupivacaine HCl 14252-80-3//Carboplatin 41575-94-4//Doxepin HCl 1229-29-4//Sodium Tauroglycocholate 41945-48-6//Nepafenac 78281-72-8//Alogliptin 850649-61-5, Find details about China Alogliptin, 850649-61-5 from Bupivacaine HCl 14252-80-3//Carboplatin 41575-94-4//Doxepin HCl 1229-29-4//Sodium Tauroglycocholate 41945-48-6//Nepafenac 78281-72-8//Alogliptin 850649-61-5

Model NO.
Alogliptin
Mf
C18h21n5o2
MW
339.39
CAS
850649-61-5
Appearance
White or off White Powder
Function
Biological and Pharmaceutical Intermediates
Shelf Life
2 Years
Test Method
HPLC UV
Storage
Cool Dry Place
Payment
Tt.Western Union .Credit Card.Moneygram
Delivery Time
Within 2 Days
Certificate
COA MSDS
Sample
Available
Trademark
Faithful
Transport Package
Aluminum Foil Bag Packaging
Specification
10g/bag; 100g/bag; 1kg/bag
Origin
China
Model NO.
Alogliptin
Mf
C18h21n5o2
MW
339.39
CAS
850649-61-5
Appearance
White or off White Powder
Function
Biological and Pharmaceutical Intermediates
Shelf Life
2 Years
Test Method
HPLC UV
Storage
Cool Dry Place
Payment
Tt.Western Union .Credit Card.Moneygram
Delivery Time
Within 2 Days
Certificate
COA MSDS
Sample
Available
Trademark
Faithful
Transport Package
Aluminum Foil Bag Packaging
Specification
10g/bag; 100g/bag; 1kg/bag
Origin
China
Bupivacaine HCl 14252-80-3//Carboplatin 41575-94-4//Doxepin HCl 1229-29-4//Sodium Tauroglycocholate 41945-48-6//Nepafenac 78281-72-8//Alogliptin 850649-61-5Bupivacaine HCl 14252-80-3//Carboplatin 41575-94-4//Doxepin HCl 1229-29-4//Sodium tauroglycocholate 41945-48-6//Nepafenac 78281-72-8//Alogliptin 850649-61-5

Introduction

NameAlogliptin
CAS850649-61-5
MFC18H21N5O2
MW339.39
EINECS821-899-3
AppearanceWhite Powder
CategoriesAPI;Inhibitor;Antihyperglycemic;Pharmaceutical

Function

Alogliptin is a dipeptidyl-peptidase IV (DPP-4) inhibitor for treatment of type 2 diabetes, a disease in which in-sulin resistance and β-cell dysfunction lead to hyperglycemia.
Application

Alogliptin is a dipeptidyl-peptidase IV (DPP-4) inhibitor for treatment of type 2 diabetes, a disease in which in-sulin resistance and β-cell dysfunction lead to hyperglycemia.

Specification
 

ItemsStandardsResults
AppearanceWhite or off-white powder, odorlessComplies
IdentificationBy IRComplies
 By HPLCComplies
Specific Rotation-5.0°~-2.5°-2.9°
Loss on Drying≤ 1.00%0.70%
Residue on Ignition≤ 0.10%0.08%
Heavy Metals≤ 20ppmComplies
Residual SolventsEthanol: ≤5000ppm700ppm
 Toluene: ≤890ppmND
Related SubstancesMaximum single impurity: ≤0.50%0.04%
 Total impurities: ≤1.00%0.12%
Assay98.0%~102.0%99.94%
Reference StandardIn-house Standard
ConclusionThe product complied to In-house standard.
StoragePreserve in tight,light-resistant containers in a cool place

 

 

Bupivacaine HCl 14252-80-3//Carboplatin 41575-94-4//Doxepin HCl 1229-29-4//Sodium Tauroglycocholate 41945-48-6//Nepafenac 78281-72-8//Alogliptin 850649-61-5Bupivacaine HCl 14252-80-3//Carboplatin 41575-94-4//Doxepin HCl 1229-29-4//Sodium Tauroglycocholate 41945-48-6//Nepafenac 78281-72-8//Alogliptin 850649-61-5Bupivacaine HCl 14252-80-3//Carboplatin 41575-94-4//Doxepin HCl 1229-29-4//Sodium Tauroglycocholate 41945-48-6//Nepafenac 78281-72-8//Alogliptin 850649-61-5Bupivacaine HCl 14252-80-3//Carboplatin 41575-94-4//Doxepin HCl 1229-29-4//Sodium Tauroglycocholate 41945-48-6//Nepafenac 78281-72-8//Alogliptin 850649-61-5Bupivacaine HCl 14252-80-3//Carboplatin 41575-94-4//Doxepin HCl 1229-29-4//Sodium Tauroglycocholate 41945-48-6//Nepafenac 78281-72-8//Alogliptin 850649-61-5Bupivacaine HCl 14252-80-3//Carboplatin 41575-94-4//Doxepin HCl 1229-29-4//Sodium Tauroglycocholate 41945-48-6//Nepafenac 78281-72-8//Alogliptin 850649-61-5Bupivacaine HCl 14252-80-3//Carboplatin 41575-94-4//Doxepin HCl 1229-29-4//Sodium Tauroglycocholate 41945-48-6//Nepafenac 78281-72-8//Alogliptin 850649-61-5

You Might Also Like